{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:42:51Z","timestamp":1791520971294,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T00:00:00Z","timestamp":1568419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T00:00:00Z","timestamp":1568419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>Atrial high rate episodes (AHREs), also termed, subclinical atrial tachyarrhythmias or subclinical atrial fibrillation (AF) are an important cardiovascular condition. Advancement in implantable cardiac devices such as pacemakers or internal cardiac defibrillators has enabled the continuous assessment of atrial tachyarrhythmias in patients with an atrial lead. Patients with device-detected AHREs are at an elevated risk of stroke and may have unmet anticoagulation needs. While the benefits of oral anticoagulation for stroke prevention in patients with clinical AF are well recognised, it is not known whether the same risk\u2013benefit ratio exists for anticoagulation therapy in patients with AHREs. The occurrence and significance of AHRE are increasingly acknowledged but these events are still not often acted upon in patients presenting with stroke and TIA. Additionally, patients with AHRE show a significant risk for major adverse cardiovascular events (MACE) including acute heart failure, myocardial infarction, cardiovascular hospitalisation, ventricular tachycardia\/fibrillation, which is dependent on AHRE burden. In this review, we present an overview of this relatively new entity, its associated thromboembolic risk and its management implications.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Graphic abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00392-019-01545-4","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T09:02:27Z","timestamp":1568451747000},"page":"409-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?"],"prefix":"10.1007","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1617-1464","authenticated-orcid":false,"given":"Ahsan A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,14]]},"reference":[{"issue":"38","key":"1545_CR1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893\u20132962","journal-title":"Eur Heart J"},{"key":"1545_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-019-01491-1","author":"T Kleemann","year":"2019","unstructured":"Kleemann T et al (2019) Prognostic relevance of new onset arrhythmia and ICD shocks in primary prophylactic ICD patients. Clin Res Cardiol. \nhttps:\/\/doi.org\/10.1007\/s00392-019-01491-1","journal-title":"Clin Res Cardiol"},{"issue":"12","key":"1545_CR3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/j.1540-8167.2006.00648.x","volume":"17","author":"JW Cheung","year":"2006","unstructured":"Cheung JW et al (2006) Newly detected atrial fibrillation following dual chamber pacemaker implantation. J Cardiovasc Electrophysiol 17(12):1323\u20131328","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"1545_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey JS et al (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366(2):120\u2013129","journal-title":"N Engl J Med"},{"issue":"9","key":"1545_CR5","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.amjcard.2012.06.034","volume":"110","author":"PD Ziegler","year":"2012","unstructured":"Ziegler PD et al (2012) Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention. Am J Cardiol 110(9):1309\u20131314","journal-title":"Am J Cardiol"},{"issue":"9","key":"1545_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s00392-018-1244-0","volume":"107","author":"D Pastori","year":"2018","unstructured":"Pastori D et al (2018) Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices. Clin Res Cardiol 107(9):772\u2013777","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"1545_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/01.CIR.89.1.224","volume":"89","author":"RL Page","year":"1994","unstructured":"Page RL et al (1994) Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89(1):224\u2013227","journal-title":"Circulation"},{"issue":"2","key":"1545_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/europace\/euw279","volume":"19","author":"AJ Camm","year":"2017","unstructured":"Camm AJ et al (2017) Atrial high-rate episodes and stroke prevention. Europace 19(2):169\u2013179","journal-title":"Europace"},{"issue":"3","key":"1545_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacc.2014.10.045","volume":"65","author":"C Chen-Scarabelli","year":"2015","unstructured":"Chen-Scarabelli C et al (2015) Device-detected atrial fibrillation: what to do with asymptomatic patients? J Am Coll Cardiol 65(3):281\u2013294","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1545_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","volume":"2","author":"TV Glotzer","year":"2009","unstructured":"Glotzer TV et al (2009) The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2(5):474\u2013480","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"16","key":"1545_CR11","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","volume":"110","author":"BF Gage","year":"2004","unstructured":"Gage BF et al (2004) Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110(16):2287\u20132292","journal-title":"Circulation"},{"issue":"6","key":"1545_CR12","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1161\/STROKEAHA.107.501825","volume":"39","author":"RG Hart","year":"2008","unstructured":"Hart RG et al (2008) Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 39(6):1901\u20131910","journal-title":"Stroke"},{"issue":"2","key":"1545_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cjca.2012.08.019","volume":"29","author":"JS Healey","year":"2013","unstructured":"Healey JS et al (2013) Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation. Can J Cardiol 29(2):224\u2013228","journal-title":"Can J Cardiol"},{"issue":"3","key":"1545_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","volume":"47","author":"H Kamel","year":"2016","unstructured":"Kamel H et al (2016) Atrial fibrillation and mechanisms of stroke. Stroke 47(3):895\u2013900","journal-title":"Stroke"},{"issue":"26","key":"1545_CR15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","volume":"36","author":"DT Martin","year":"2015","unstructured":"Martin DT et al (2015) Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J 36(26):1660\u20131668","journal-title":"Eur Heart J"},{"issue":"9","key":"1545_CR16","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.hrthm.2011.04.022","volume":"8","author":"EG Daoud","year":"2011","unstructured":"Daoud EG et al (2011) Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm 8(9):1416\u20131423","journal-title":"Heart Rhythm"},{"issue":"1 Pt 2","key":"1545_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1540-8159.1998.tb01098.x","volume":"21","author":"P Defaye","year":"1998","unstructured":"Defaye P, Dournaux F, Mouton E (1998) Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. The AIDA Multicenter Study Group Automatic Interpretation for Diagnosis Assistance. Pacing Clin Electrophysiol 21(1 Pt 2):250\u2013255","journal-title":"Pacing Clin Electrophysiol"},{"issue":"9","key":"1545_CR18","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/europace\/euv310","volume":"17","author":"D Todd","year":"2015","unstructured":"Todd D et al (2015) How are arrhythmias detected by implanted cardiac devices managed in Europe? Results of the European Heart Rhythm Association Survey. Europace 17(9):1449\u20131453","journal-title":"Europace"},{"issue":"12","key":"1545_CR19","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","volume":"107","author":"TV Glotzer","year":"2003","unstructured":"Glotzer TV et al (2003) Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 107(12):1614\u20131619","journal-title":"Circulation"},{"issue":"4 Pt 1","key":"1545_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1540-8159.1998.tb00125.x","volume":"21","author":"K Seidl","year":"1998","unstructured":"Seidl K et al (1998) Is the atrial high rate episode diagnostic feature reliable in detecting paroxysmal episodes of atrial tachyarrhythmias? Pacing Clin Electrophysiol 21(4 Pt 1):694\u2013700","journal-title":"Pacing Clin Electrophysiol"},{"key":"1545_CR21","unstructured":"Dhutia H (2019) Impact and Management of Atrial High Rate Events Detected by Implantable Cardiac Devices. BCS Editorials 2017 3rd July 2019]; \nhttps:\/\/www.bcs.com\/pages\/news_full.asp?NewsID=19792648\n\n. Accessed 16 July 2019"},{"issue":"8","key":"1545_CR22","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.hrthm.2012.03.017","volume":"9","author":"ES Kaufman","year":"2012","unstructured":"Kaufman ES et al (2012) Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT. Heart Rhythm 9(8):1241\u20131246","journal-title":"Heart Rhythm"},{"issue":"4","key":"1545_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.ahj.2004.06.032","volume":"149","author":"GC Flaker","year":"2005","unstructured":"Flaker GC et al (2005) Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 149(4):657\u2013663","journal-title":"Am Heart J"},{"issue":"10","key":"1545_CR24","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1161\/STROKEAHA.112.654954","volume":"43","author":"T Rizos","year":"2012","unstructured":"Rizos T et al (2012) Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke 43(10):2689\u20132694","journal-title":"Stroke"},{"issue":"12","key":"1545_CR25","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1161\/STROKEAHA.113.001884","volume":"44","author":"M Grond","year":"2013","unstructured":"Grond M et al (2013) Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study. Stroke 44(12):3357\u20133364","journal-title":"Stroke"},{"issue":"12","key":"1545_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrcardio.2017.94","volume":"14","author":"B Freedman","year":"2017","unstructured":"Freedman B et al (2017) Management of atrial high-rate episodes detected by cardiac implanted electronic devices. Nat Rev Cardiol 14(12):701\u2013714","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"1545_CR27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","volume":"35","author":"G Boriani","year":"2013","unstructured":"Boriani G et al (2013) Device-detected atrial fibrillation and risk for stroke: an analysis of %3e10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J 35(8):508\u2013516","journal-title":"Eur Heart J"},{"key":"1545_CR28","doi-asserted-by":"crossref","unstructured":"Pastori D et al (2019) Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices. Clin Res Cardiol","DOI":"10.1007\/s00392-019-01493-z"},{"issue":"3","key":"1545_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/01.CIR.0000109490.72104.EE","volume":"109","author":"CR Kerr","year":"2004","unstructured":"Kerr CR et al (2004) Canadian trial of physiological pacing: effects of physiological pacing during long-term follow-up. Circulation 109(3):357\u2013362","journal-title":"Circulation"},{"issue":"1","key":"1545_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0735-1097(01)01326-2","volume":"38","author":"AC Skanes","year":"2001","unstructured":"Skanes AC et al (2001) Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. J Am Coll Cardiol 38(1):167\u2013172","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1545_CR31","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/europace\/eux356","volume":"20","author":"SB Uittenbogaart","year":"2017","unstructured":"Uittenbogaart SB et al (2017) Burden of atrial high-rate episodes and risk of stroke: a systematic review. EP Europace 20(9):1420\u20131427","journal-title":"EP Europace"},{"issue":"3","key":"1545_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/europace\/euu267","volume":"17","author":"J Benezet-Mazuecos","year":"2015","unstructured":"Benezet-Mazuecos J et al (2015) Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices. Europace 17(3):364\u2013369","journal-title":"Europace"},{"issue":"5","key":"1545_CR33","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCEP.114.003057","volume":"8","author":"MP Turakhia","year":"2015","unstructured":"Turakhia MP et al (2015) Atrial fibrillation burden and short-term risk of stroke: case-crossover analysis of continuously recorded heart rhythm from cardiac electronic implanted devices. Circ Arrhythm Electrophysiol 8(5):1040\u20131047","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"17","key":"1545_CR34","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","volume":"38","author":"IC Van Gelder","year":"2017","unstructured":"Van Gelder IC et al (2017) Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J 38(17):1339\u20131344","journal-title":"Eur Heart J"},{"issue":"4","key":"1545_CR35","first-page":"1249","volume":"8","author":"ED Maria","year":"2015","unstructured":"Maria ED, Giacopelli D (2015) Subclinical atrial tachyarrhythmias: implantable devices and remote monitoring. J Atr Fibrillation 8(4):1249\u20131249","journal-title":"J Atr Fibrillation"},{"issue":"10","key":"1545_CR36","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","volume":"46","author":"A Capucci","year":"2005","unstructured":"Capucci A et al (2005) Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 46(10):1913\u20131920","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1545_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1540-8167.2008.01320.x","volume":"20","author":"GL Botto","year":"2009","unstructured":"Botto GL et al (2009) Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 20(3):241\u2013248","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"26","key":"1545_CR38","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","volume":"370","author":"DJ Gladstone","year":"2014","unstructured":"Gladstone DJ et al (2014) Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 370(26):2467\u20132477","journal-title":"N Engl J Med"},{"issue":"21","key":"1545_CR39","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1212\/01.wnl.0000325059.86313.31","volume":"71","author":"AH Tayal","year":"2008","unstructured":"Tayal AH et al (2008) Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology 71(21):1696\u20131701","journal-title":"Neurology"},{"issue":"21","key":"1545_CR40","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","volume":"129","author":"M Brambatti","year":"2014","unstructured":"Brambatti M et al (2014) Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 129(21):2094\u20132099","journal-title":"Circulation"},{"issue":"12","key":"1545_CR41","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.hrthm.2014.08.019","volume":"11","author":"M Gonzalez","year":"2014","unstructured":"Gonzalez M et al (2014) Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers. Heart Rhythm 11(12):2214\u20132221","journal-title":"Heart Rhythm"},{"issue":"8","key":"1545_CR42","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/europace\/eut227","volume":"15","author":"D Dobreanu","year":"2013","unstructured":"Dobreanu D et al (2013) Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. Europace 15(8):1223\u20131225","journal-title":"Europace"},{"key":"1545_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ahj.2017.04.008","volume":"189","author":"RD Lopes","year":"2017","unstructured":"Lopes RD et al (2017) Rationale and design of the apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation (ARTESiA) trial. Am Heart J 189:137\u2013145","journal-title":"Am Heart J"},{"key":"1545_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ahj.2017.04.015","volume":"190","author":"P Kirchhof","year":"2017","unstructured":"Kirchhof P et al (2017) Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J 190:12\u201318","journal-title":"Am Heart J"},{"issue":"4","key":"1545_CR45","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1046\/j.1460-9592.2001.00424.x","volume":"24","author":"WM Pollak","year":"2001","unstructured":"Pollak WM et al (2001) Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter. Pacing Clin Electrophysiol 24(4):424\u2013429","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"1545_CR46","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.hrthm.2017.11.007","volume":"15","author":"G Boriani","year":"2018","unstructured":"Boriani G et al (2018) Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden. Heart Rhythm 15(3):376\u2013383","journal-title":"Heart Rhythm"},{"issue":"7","key":"1545_CR47","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.hrthm.2016.03.013","volume":"13","author":"MV Orlov","year":"2016","unstructured":"Orlov MV et al (2016) Atrial electrograms improve the accuracy of tachycardia interpretation from ICD and pacemaker recordings: the RATE Registry. Heart Rhythm 13(7):1475\u20131480","journal-title":"Heart Rhythm"},{"issue":"2","key":"1545_CR48","doi-asserted-by":"publisher","first-page":"e010954","DOI":"10.1136\/heartasia-2017-010954","volume":"9","author":"H Kawakami","year":"2017","unstructured":"Kawakami H et al (2017) Clinical significance of atrial high-rate episodes for thromboembolic events in Japanese population. Heart Asia 9(2):e010954","journal-title":"Heart Asia"},{"key":"1545_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijcard.2019.04.055","volume":"292","author":"YG Li","year":"2019","unstructured":"Li YG et al (2019) Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: the West Birmingham Atrial Fibrillation Project. Int J Cardiol 292:126\u2013130","journal-title":"Int J Cardiol"},{"issue":"9","key":"1545_CR50","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s00392-019-01432-y","volume":"108","author":"K Miyazawa","year":"2019","unstructured":"Miyazawa K et al (2019) Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes. Clin Res Cardiol 108(9):1034\u20131041","journal-title":"Clin Res Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-019-01545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-019-01545-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-019-01545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T23:12:12Z","timestamp":1599952332000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-019-01545-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,14]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1545"],"URL":"https:\/\/doi.org\/10.1007\/s00392-019-01545-4","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,14]]},"assertion":[{"value":"17 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"GYHL has served as a consultant for Bayer\/Janssen, BMS\/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Microlife and Daiichi-Sankyo; and a speaker for Bayer, BMS\/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche and Daiichi-Sankyo. No personal fees received. GB has received small speaker\u2019s fees from Medtronic, Boston, Boehringer, and Bayer, outside of the submitted work. AAK has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}